New York (December 19th, 2012) - BG Medicine, Inc. (NASDAQ: BGMD) 2.74 -0.15 (-5.19%). BG Medicine, Inc. (BGMD) announced on Dec 11th that it has obtained a CE Mark enabling the commercial sale of the CardioSCORE™ test in the EU and other countries that recognize the CE Mark. The CardioSCORE test is the company's patented diagnostic blood test designed to dramatically improve risk prediction of major cardiovascular events beyond traditional risk factor assessments, such as the Framingham Risk Score and European SCORE. BG Medicine, Inc., is a United States-based company, which provides drug research and development services.
The Company focused on the discovery, development, and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs.
Find out if this the right time to trade or invest in BGMD by getting the free full report here: http://www.wallstreetscoop.net/market-scan/?symbol=BGMD
City Telecom (H.K.) Limited (ADR) (NASDAQ:CTEL) 6.06 -0.19 (-3.04%). On Dec 13th City Telecom (H.K.) Limited's Hong Kong broadband network ltd announced partnership with Yahoo! Hong Kong . CTEL provides international telecommunications services. The Company engages itself in services that encompass voice, fax, data and the internet. It is engaged in the provision of international telecommunications and fixed network services. The Company offers telecommunications services including IDD1666 Service, 888 Calling Card Service, Prepaid Cards Service, Call Forward Service and Get Fax Easy Service and PilipinasLink Card.
Find out where CTEL could be headed by getting the free full report here: